Skip to main content

Advertisement

  • Research
  • Open Access

Hospital clones of methicillin-resistant Staphylococcus aureus are carried by medical students even before healthcare exposure

  • 1,
  • 2,
  • 1, 3,
  • †1, 4 and
  • †1, 5Email author
†Contributed equally
Antimicrobial Resistance & Infection Control20176:15

https://doi.org/10.1186/s13756-017-0175-2

©  The Author(s). 2017

  • Received: 27 October 2016
  • Accepted: 12 January 2017
  • Published:

Abstract

Background

Methicillin-resistant Staphylococcus aureus (MRSA) strains are prevalent in healthcare and the community. Few studies have examined MRSA carriage among medical students.

The aim of this study is to examine Staphylococcus aureus (SA) carriage, and particular MRSA, over time in cohort medical students

Methods

Prospective collection of nasal swabs from medical students in Israel and assessment of SA carriage. Three samples were taken per student in preclinical and clinical parts of studies. Antibiotic susceptibilities were recorded and MRSA typing was performed by staphylococcal cassette chromosome mec (SCCmec) types, Panton Valentine Leukocidin (PVL) encoding genes, and spa types. Clonality was assessed by pulsed-field gel electrophoresis.

Results

Among 58 students, SA carriage rates increased from 33% to 38% to 41% at baseline (preclinical studies), 13 and 19 months (clinical studies), respectively (p = 0.07). Methicillin-susceptible SA (MSSA) carriage increased in the clinical studies period (22 to 41%, p = 0.01). Overall, seven students (12%) carried 13 MRSA isolates. MRSA isolates were PVL negative and were characterized as SCCmecII-t002, SCCmecIV-t032, or t12435 with untypable SCCmec. MRSA carriage during the pre-clinical studies was evident in 4/7 students. Two students carried different MRSA clones at various times and persistent MRSA carriage was noted in one student. Simultaneous carriage of MRSA and MSSA was not detected.

Conclusions

MSSA carriage increased during the clinical part of studies in Israeli medical students. Compared with previous reports, higher rates of MRSA carriage were evident. MRSA strains were genotypically similar to Israeli healthcare-associated clones; however, carriage occurred largely before healthcare exposure, implying community-acquisition of hospital strains.

Keywords

  • Methicillin-resistance
  • Review
  • Staphylococcus aureus
  • Carriage
  • Medical students
  • Community-associated
  • Healthcare-associated

Background

Staphylococcus aureus (SA) is a versatile pathogen capable of colonizing humans and mammals, and causing skin and invasive diseases such as endocarditis, osteomyelitis, and severe sepsis. Methicillin-resistant SA (MRSA) was reported in 1961, soon after the introduction of the semisynthetic penicillin, methicillin [1]. Until the 1990s, MRSA strains were associated mostly with hospitals and infected patients who had contact with the healthcare system, hence the name healthcare-associated MRSA (HA-MRSA). These strains were typically resistant to multiple antimicrobials (multi-drug resistant – MDR) and carried large staphylococcal cassette chromosome mec (SCCmec) elements, mostly types I-III [2]. Beginning in the late 1990s, community-associated strains of MRSA (CA-MRSA) were described with increasing incidence, colonizing and infecting patients who had no recent contact with the healthcare system. These strains were usually non-MDR, carried small SCCmec elements, mostly types IV and V, and also carried the genes encoding the Panton-Valentine leukocidin (PVL), a pore-forming toxin rarely found among SA isolates [1]. Nowadays, in many geographic regions there are no longer lineages, genetic markers, or susceptibility phenotypes that are indicative for specific epidemiological origins such as HA-MRSA or CA-MRSA [1].

The primary reservoir of SA is the anterior nares, but the organism can be isolated from multiple sites. The prevalence and incidence of SA nasal carriage vary according to the population studied. According to multiple cross-sectional surveys, the mean carriage rate across the general population is 37% [3]. Regarding MRSA carriage in the era of CA-MRSA, the overall MRSA carriage rate in the United States has increased from 0.8% in 2001–2002 to 1.5% in 2003–2004, and it is particularly important in the hospital environment because colonized and infected patients represent the most important reservoir of MRSA in healthcare facilities [4, 5].

The carriage of MRSA among healthcare workers (HCW) due to the relation of their exposure to patients harboring these strains is a well-known phenomenon [6]. Medical students seem to be no exception, as their clinical study environment involves various medical settings such as hospitals and community clinics, which may contribute to their carriage status. In a non-systematic review of the English literature we found several studies, conducted worldwide, investigating SA carriage among medical students (Table 1) [7–32]. These studies reported MRSA carriage rates of 0–5.4% and SA carriage rates of 14–45% (excluding a small study from India reporting a higher carriage rate and a study from Canada of dental students [12, 15]). Only in a minority of these studies assessed the difference of SA carriage between pre-clinical and clinical medical students and most investigations assessed carriage at a single time-point only [7, 9, 21–23, 26, 27, 31]. Of these, three studies demonstrated higher SA carriage rates in the clinical studies stage [9, 23, 26]. Furthermore, only a single study from Thailand had prospectively examined the change in SA carriage in the same group of medical students over multiple sampling times [26]. Therefore, we aimed to prospectively examine the change in SA carriage among medical students transitioning from pre-clinical to clinical education with a focus on MRSA. Moreover, we aimed to characterize MRSA isolates from medical students using SCCmec and spa typing as well as PFGE.
Table 1

Staphylococcus aureus carriage among medical students in published papers

Year

Reference

Country

Population

SA Carriage, n (%)

MRSA Carriage, n (%)

Notes

Total

Pre-clinical group

Clinical group

Total

Pre-clinical group

Clinical group

1994

Stubbs et al. [7]

Australia

N = 808

261/808 (30%)

68/193 (35%)

252/615 (40%)

0

0

0

 

2004

Berthelot et al. [8]

France

N = 124

34/124 (27%)

N/A

N/A

1/124) (1%)

N\A

N/A

 

2007

Güçlü et al. [9]

Turkey

N = 179

50/179 (28%)

12/179 (15%)

38/179 (76%)a

N/A

N/A

N/A

 

2007

Higuchi et al. [10]

Japan

N = 98

36/98 (36%)

N/A

N/A

0

0

0

 

2007

Adesida et al. [11]

Nigeria

N = 182

26/182 (14%)

N/A

N/A

0

0

0

 

2008

Baliga et al. [12]

India

N = 50

44/50 (88%)

N/A

N/A

12/50 (24%)

N/A

N/A

 

2009

Slifka et al. [13]

USA

N = 182

62/182 (34%)

N/A

N/A

5/182 (3%)

2/95(2%)

3/87 (3%)

 

2011

Ma et al. [14]

China

N = 2103b

212/2103 (10%)

N/A

N/A

22/2103 (1%)

N/A

N/A

SCCmec I, ST88 PVL- (n = 1);

SCCmec II, ST5 PVL+ (n = 1) PVL- (n = 1);

SCCmec III, ST 239 PVL- (n = 1);

SCCmec IVa, ST88 PVL+ (n = 5), PVL-(n = 3), ST30 (n = 1), ST1, PVL+ (n = 1); SCCmec IVn,ST59 (n = 2); SCCmec IVc, ST30,PVL+ (n = 2)

SCCmec V, ST59 PVL+ (n = 2), ST90 PVL- (n = 1); non typable (n = 1)

2011

Roberts et al. [15]

Canada

N = 61c

N/A

N/A

N/A

13/61 (21%)

N/A

N/A

SCCmec IV, ST1159 (n = 1);

12 NT*,HA [ST8,ST30 (n = 3), ST39, ST45, ST101, ST109, ST256 (n = 2), ST 1474, ST1474]

2011

Chamberlain et al. [16]

USA

N = 132

62/132 (47%)

N/A

N/A

7/132 (5%)

N/A

N/A

 

2011

Kitti et al. [17]

Thailand

N = 200

30/200 (15%)

N/A

N/A

2/200 (1%)

N/A

N/A

SCCmec II (n = 2)

2012

Gualdoni et al. [18]

Austria

N = 79

20/79 (25%)

N/A

N/A

0

N/A

N/A

 

2012

Bettin et al. [19]

Colombia

N = 387

96/387 (25%)

N/A

N/A

6/387 (2%)

N/A

N/A

SCCmec I, PVL- (n = 1); SCCmec IV, PVL+ (n = 5) CA

2012

Mahmutović Vranić et al. [20]

Bosnia

N = 387

39/387 (11%)

N/A

N/A

0

N/A

N/A

 

2012

Chen et al. [21]

Taiwan

N = 322

55/322 (17%)

24/167 (14%)

31/155 (20%)

7/322 (2%)

4/167 (2%)

3/155 (2%)

SCCmec IV, ST59 (n = 2), N/A MLST (n = 4), PVL – (n = 6)CA

SCCmec VT, ST59, PVL+ (n = 1)CA

2012

Syafinaz et al. [22]

Malaysia

N = 209

21/209 (10%)

14/111 (13%)

7/97 (7%)

0

0

0

 

2013

Bellows et al. [23]

USA

N = 94

15/94 (16%)

3/42 (7%)

12/52 (23%)a

3/94 (3%)

0

3/52 (6%)

 

2013

Cirković et al. [24]

Serbia

N = 533

N/A

N/A

N/A

2/533 (0.4%)

N/A

N/A

SCCmec IV, ST80CA

SCCmec V,ST152CA

2013

Trépanier et al. [25]

Canada

N = 497d

N/A

N/A

N/A

1/497 (0.2%)

1/247 (0.4%)

0

 

2014

Treesirichod et al. [26]

Thailand

N = 128

42/127 (33%)

38/128 (30%)

2nd sample 39/128 (31%)

3rd sample 50/127 (39%)a

0

0

0

3 prospective samples

2015

Zakai et al. [27]

Saudi Arabia

N = 182

60/182 (32%)

32/32 (100%)

28/150 (19%)

10/182 (5%)

0/32

10/150 (7%)

 

2015

Collazos Marín et al. [28]

Colombia

N = 216

54 (25%)

N/A

N/A

9/216 (4%)

N/A

N/A

4/9 (44%)CA

2015

Ho et al. [29]

China

N = 1149

526/1149 (45%)

N/A

N/A

6/1149 (1%)

N/A

N/A

SCCmec IV,t437 (n = 3)CA :PVL+ (n = 1)

t11642 (n = 1)CA, t1081 (n = 1)HA, t267 (n = 1)HA

2016

Baek et al. [30]

South Korea

N = 159c

N/A

N/A

N/A

5/159 (3%)

N/A

 

SCCmec IV (n = 4)

SCCmec I (n = 1)

2016

Okamo et al. [31]

Tanzania

N = 314

66/314 (21%)

33/166 (20%)

33/148 (22%)

1/314 (0.3%)

N/A

N/A

 

2016

Ansari et al. [32]

Nepal

N = 200

30/200 (15%)

N/A

N/A

8/200 (4%)

N/A

N/A

 

N/A not available, CA-MRSA community-associated methicillin-resistant Staphylococcus aureus, HA-MRSA hospital-associated methicillin-resistant Staphylococcus aureus, SA Staphylococcus aureus, SCCmec Staphylococcal Cassette Chromosome mec

a p < 0.05

bMedical interns

cDental students

dDivided to 250 medical residents and 247 undergrad students including interns

HAsuggested by article as HA-MRSA

CASuggested by article as CA-MRSA

*Not SCCmec type I-V

Methods

Study population

The study population included medical students at the Faculty of Medicine in the Galilee of Bar-Ilan University, in Safed, Israel. The Faculty has two academic classes: 4-year and 3-year tracks. The 3-year track students finished 3 years of pre-clinical medical education in medical faculties across Europe (such as Hungary, Italy, and Lithuania). Almost all of these students reported no patient encounters during their studies, as most of their education was lecture-based. The 4-year track students have graduated from various pre-med Israeli academic institutions. As no dormitories are available, most students live separately. The study was approved by the local Ethics Committees of Baruch Padeh Medical Center, Poriya, and Bar-Ilan University.

Sampling

Samples were collected three times for each participant during 2012–2014. Sampling was made by a sterile swab (COPAN, Italy) from the nostrils, independently by the participant. First sampling was performed towards the end of pre-clinical studies, with second and third samplings collected at 13 and 19 months post-initial sampling while students were rotating in clinical clerkships. All samples were kept at room temperature for a maximum of 24 h before being transferred to the microbiology laboratory.

Staphylococcus aureus identification

Microbiological examinations were performed at the Baruch Padeh Medical Center Microbiology Laboratory in Poriya, Israel. Primary culture was performed by striking technique in order to perform culture and colony isolation on a selective chromogenic growth medium (Chromagar MRSA/MSSA, hylabs, Israel). Confirmatory tests for SA included gram staining, catalase test, and rapid agglutination test for simultaneous detection of the fibrinogen affinity antigen (clumping factor), protein A, and the capsular polysaccharides (Pastorex™ Staph Plus, BIO RAD, France).

Susceptibility tests

Antimicrobial susceptibility tests were performed by disc diffusion method on Muller-Hinton agar (BD Diagnostics, Sparks, MD) in accordance with the Clinical and Laboratory Standards Institute (CLSI) guidelines for rifampicin, vancomycin, erythromycin, gentamicin, cefotaxime, clindamycin, penicillin, oxacillin, mupirocin, fusidic acid, tetracycline, trimethoprim-sulfamethoxsazole (TMP-SMX), and cefoxitin [33]. MDR for MRSA was defined as resistance to at least three antimicrobial agents in addition to β-lactams.

Molecular characteristics

Typing of MRSA strains was performed at the National Staphylococcus aureus Reference Center, Central Laboratories, Israel Ministry of Health, Jerusalem, Israel.

PCR detection of mecA and PVL genes

PCR reactions in a total volume of 23 mL included 10.5 mL DDW, 12.5 mL PCR mix (ReddyMix, Tamar Laboratory Supplies, Mevaseret Zion), MecA1 and MecA2 primers or Luk-PV-1 and Luk-PV-2 primers (1 mM each). Thermocycling conditions were set at 94 °C for 2 min followed by 30 cycles of 94 °C for 30 s, 55 °C for 30 s, 72 °C for 60 s, followed by a final step of 72 °C for 2 min [34, 35].

Detection of SCCmec types

SCCmec types were detected using the method of Zhang et al. [35]. PCR reactions were performed in a total volume of 20 mL, including 9.5 mL DDW, 9.5 mL PCR mix (ReddyMix, Tamar Laboratory Supplies, Mevaseret Zion), and 1 mL primer mix with a final concentration as recommended [35]. Thermocycling conditions were set at 95 °C for 5 min, followed by 11 cycles of 94 °C for 45 s, 65 °C for 45 s, 72 °C for 1.5 min, followed by 26 cycles of 94 °C for 45 s, 55 °C for 45 s, 72 °C for 1.5 min, and a final step of 72 °C for 10 min [35].

spa typing

spa typing was performed in a 20 mL reaction including 9.5 mL DDW, 9.5 mL PCR mix (ReddyMix, Tamar Laboratory Supplies, Mevaseret Zion), and primers 1514R, 1113 F (4pmol each). Thermocycling conditions were set at 94 °C for 5 min, followed by 35 cycles of 94 °C for 45 s, 60 °C for 45 s, 72 °C for 90 s, followed by a final extension step of 72 °C for 10 min. Cycle sequencing was carried out using the BigDye Terminator v1.1 chemistry (Applied Biosystems, Foster City, CA, USA) according to manufacturer’s protocol. Cycle sequencing products were purified by gel using Performa DTR according to the manufacturer’s recommendation. Electrophoresis was carried out on a 3730 × l Genetic Analyzer (Applied Biosystems) and the analysis was done using sequencing Analysis v.5.3.1 software (Applied Biosystems). spa typing analysis was performed using BioNumerics 7.5 software [36].

PFGE

Agarose-embedded (Lonza, USA) SA DNA was digested with SmaI (Fermentas, Lithuania) followed by gel electrophoresis in the CHEF MAPPER (Bio-Rad) system. Electrophoresis conditions were 14 °C, 0.5 × Tris-borate-EDTA buffer (Sigma, Switzerland), initial pulse 5 s, final pulse 50 s, 6 V, 18 h. Salmonella Braenderup H9812 restricted with XbaI (Fermentas, Lithuania) was used as a marker. PFGE restriction patterns were analyzed by the BioNumerics software (Applied Maths). The pulsotypes were compared using the band-based DICE similarity coefficient with 1% optimization and tolerance. The un-weighted pair group method with arithmetic mean (UPGMA) algorithm was used for cluster analysis [37].

Statistical analysis

Statistical analysis was performed using SPSS for windows version 21 (IBM Analytics). Proportion tests, Chi-square tests, and Wilcoxon signed ranks test were used for the univariate analysis using α = 0.05 and 95% confidence interval (CI). Statistical significance was based on p ≤ 0.05.

Results

A total of 58/109 students of the 2012 class (53%) participated in our study: 31 students of the 4-year track and 27 students of the 3-year track. There were 30 females and 28 males; the age range was 23–35 years. All 58 students participated during the entire study; three samples were taken from each of these students. Overall, 65 SA isolates were cultured from 32 students in the entire study period: 13 MRSA strains from seven students and 52 MSSA strains from 28 students.

First sample (pre-clinical sampling)

Overall, 19 (33%) SA isolates were cultured from 7 (12%) students of the three-year track and 12 (20%) students of the 4-year track (Figs. 1 and 2). Four (7%) MRSA isolates were identified: three from students of the 4-year track (10%) and one from a student of the 3-year track (4%). No significant differences in the rates of MSSA and MRSA isolation between the medical tracks were noted (p = 0.5; Fig. 2).
Fig. 1
Fig. 1

Staphylococcus aureus carriage rates among medical students by sample

Fig. 2
Fig. 2

Carriage rates of Staphylococcus aureus isolates according to medical track and sampling time

Second sample (first clinical sampling)

Thirteen months after the first pre-clinical samples, 22 SA (38%) isolates were cultured from 30% (eight of 27) of the 3-year track students and 45% (14 of 31) of the 4-year track students (Figs. 1 and 2). Further analysis revealed 16 MSSA (28%) and 6 MRSA isolates (10%) (Fig. 1). No significant differences were noted in the rates of MSSA and MRSA isolation between the medical tracks (p = 0.47) or between the first and second samples (p = 0.76; Fig. 2).

Third sample (second clinical sampling)

The last sample took place 6 months following the second sample and included 24 (41%) SA isolates cultured from 44% (12 of 27) of the 3-year track students and 39% (12 of 31) of the 4-year track students (Figs. 1 and 2). Overall, 21 MSSA (36%) and three MRSA isolates (5%) were identified. No significant differences in the rates of MSSA and MRSA isolation between the medical tracks were noted (p = 0.74). Compared with the second sample, an increase in the carriage rate of MSSA was noted in students of the 3-year track (p = 0.01; Fig. 2). Non-significant increases in the overall SA carriage between the pre-clinical sample and the third sample (p = 0.21) and between the second sample and the third sample (p = 0.07) were noted.

Phenotypic and genotypic characterization of MRSA isolates

The mecA gene was detected in all MRSA isolates. According to PFGE analysis, three closely-related clones of MRSA strains were identified (Fig. 3, Table 2) [37]. The first clone was isolated exclusively from the 4-year track students; this clone carried SCCmec IV, was PVL negative, and typed as spa type t032. The second clone was isolated from a single student of the 3-year track and was PVL negative, spa type t12435, with an untypable SCCmec. The third clone was cultured from students in both medical tracks and carried SCCmec II, was PVL negative, and typed as spa type t002.
Fig. 3
Fig. 3

Pulsed-field gel electrophoresis analysis of methicillin-resistant Staphylococcus aureus strains found in the study. * The numbers represent the students with MRSA carriage as mentioned in Fig. 4; the capital letters represent the sample time. For example: 1C is a clone cultured from student 1 on the third sample of the study

Table 2

Summary of molecular characteristics of carried methicillin-resistant Staphylococcus aureus strains

 

3-year track (n = 4)

4-year track (n = 9)

Total (n = 13)

SCCmec II, t002

2

5

7

SCCmec IV, t032

0

4

4

t12435a

2

0

2

aUntypable SCCmec

All MRSA Isolates were PVL-negative

Staphylococcal Cassette Chromosome mec (SCCmec)

Overall, 38% of MRSA isolates (5 out of 13) were resistant to clindamycin whereas only 6% of MSSA isolates were clindamycin resistant (p = 0.01; Table 3). Clindamycin resistance rates differed among the various MRSA clones: half of SCCmec II, t002 isolates were resistant while none were resistant in the SCCmec IV, t032 clone. All MRSA isolates were susceptible to TMP-SMX, tetracycline, rifampicin, fusidic acid, mupirocin, and vancomycin, and were non-MDR.
Table 3

Antibiotic resistance rates of Staphylococcus aureus isolates

 

3-year program

4-year program

Total

 

MSSA (n = 23)

MRSA (n = 4)

MSSA (n = 29)

MRSA (n = 9)

MSSA (n = 52)

MRSA (n = 13)

Ciprofloxacin

0%

0%

3%

22%

2%

15%

Clindamycin

4%

100%

7%

11%

6%

38%

Erythromycin

60%

25%

21%

22%

38%

23%

Gentamicin

17%

75%

3%

44%

10%

54%

All isolates were susceptible to trimethoprim-sulfamethoxazole (TMP-SMX), fusidic acid, mupirocin, tetracycline, rifampin, and vancomycin

MSSA Methicillin-susceptible Staphylococcus aureus, MRSA Methicillin-resistant Staphylococcus aureus

Carriage of MRSA over multiple sampling times

Five of the seven (71%) students who were colonized with MRSA carried the bacterium in more than one sample (Fig. 4); two students carried different MRSA clones at various sampling times. Four students (57%) had MRSA carriage during the pre-clinical studies. None of the students carried MRSA and MSSA simultaneously.
Fig. 4
Fig. 4

Time-line of methicillin-resistant S. aureus carriage

Discussion

The carriage of SA increased in medical students along the sampling time (33, 38, and 41%, respectively). A non-significant increase (p = 0.07) was noted in the overall rise of SA carriage. However, a statistically significant increase in the MSSA carriage among the 3-year track students was evident when the second sample was compared with the third; both were taken during the clinical stages of studies. Thus, it is possible that a larger sample would also lead to a significant overall rise in SA carriage between the preclinical and clinical parts of the studies. This was indeed observed in three of eight studies comparing preclinical and clinical medical students [9, 23, 26].

In the multiple samplings we performed, up to 10% of the students carried MRSA. This rate is higher than observed in other studies looking at medical students, where carriage rates of 0–5.4% were noted (Table 1). In fact, according to a systematic review of MRSA carriage among healthcare workers in Europe and the United States, it is close to the reported carriage rates of nursing staff [6]. Possible explanations for this difference in rates of MRSA carriage among medical students may be from various sampling times in the studies, MRSA prevalence rates in hospitals and communities in different countries, and the relatively small sample size of studies.

The MRSA strains we isolated are compatible with HA-MRSA strains. We base this observation on the molecular characteristics of the strains and epidemiologic studies from Israel. Both SCCmec II, t002 and SCCmec IV, t032 are common hospital MRSA strains in Israel [38, 39]. Indeed, SCCmec II, t002 is reported to be the second most common clone in Israeli hospitals [38]. Although mostly described in CA-MRSA strains, up to 30% of HA-MRSA isolates in Israel carry SCCmec types IV and V [38, 39]. A recent report of community-onset MRSA in Israel demonstrated SCCmec IV, t032 to represent nearly 30% of SCCmec IV isolates; thus this strain is commonly isolated both in Israeli hospitals and in patients from the community [40]. In contrast, typical CA-MRSA strains in Israel have different genotypes: USA300 (SCCmec IV, t008, PVL+) and SCCmec IV, t991, PVL- [40]. The third strain in our study, t12435, is relatively rare, being isolated only a few times from hospitalized patients in northern Israel according to data from the Israeli National Staphylococcus aureus Reference Center. Although non-MDR phenotype of MRSA is commonly described among CA-MRSA strains, this phenotype was also common among SCCmec IV, t032 isolates from Israeli hospitals with relatively low clindamycin resistance rates [1, 2, 40]. Our findings differ from other reports of MRSA in medical students: predominantly CA-MRSA clones (as suggested by the authors) were isolated from medical students in China, Serbia, Canada, Colombia and Taiwan, suggesting these countries have a different MRSA epidemiology [15, 19, 21, 24, 28, 29].

Two additional observations are worth mentioning: we did not find new, non-local MRSA clones among the students, although the 3-year track students arrived from various countries in Europe. This probably implies acquisition of MRSA clones in Israel but can also represent acquisition of global MRSA strains from Europe [41]. The second observation is that although students carried MRSA isolates compatible with HA-MRSA clones, the acquisition of the majority of MRSA isolates, including two of three clones, took place before the clinical part of the studies, namely before the exposure to the healthcare system occurred. Indeed, 80% of community-onset MRSA isolates among patients insured by a large health maintenance organization in Israel were recently shown to be of nosocomial origin [40]. This can explain the acquisition of HA-MRSA clones by students before clinical rotations. Another explanation may be that some students had unrecognized healthcare exposure early in their studies.

In assessing carriage over time, we observed that in two students multiple MRSA clones were carried on different occasions. Compared with MSSA, less is known about the natural history of MRSA carriage and therefore comparison to MSSA data may seem tempting. However, this comparison is problematic as the variety of genotypes and prevalence in the community is larger for MSSA in most geographic locales [1, 3]. Carrying multiple genotypes of MRSA over time may imply acquisition of a new strain from a fellow student or during healthcare exposure. Furthermore, we noticed that only one of seven students colonized with MRSA can be defined as a persistent carrier and even so with multiple genotypes. Lastly, we observed that there was no simultaneous carriage of MRSA and MSSA isolates. Simultaneous carriage of MRSA and MSSA was previously reported either as a rare occurrence, assuming competition for colonization space and nutrients, or in contrast, as a relatively common occurrence [42, 43].

Our study had some limitations. The number of students participating was relatively small and the sampling was not done simultaneously in all students. The nose was the only site tested. Additionally, only one medical school participated. This may limit the power of the study and the generalization for all areas of Israel. The strengths of the study are in the prospective collection of data over multiple times in preclinical and clinical parts of the students’ education, the participation of all students during the whole study, and the genotyping of MRSA strains.

Conclusion

MSSA carriage rates increased during the clinical part of the studies in medical students in Israel. Higher rates of MRSA carriage were evident in this study compared with previous reports of medical students. MRSA strains carried were genotypically similar to healthcare-associated clones in Israel; however, MRSA carriage occurred in the majority of students before healthcare exposure, probably representing community-acquisition of hospital strains. Until official recommendations regarding screening and interventions for MRSA in medical students will be published, a call for good personal hygiene is in place.

Abbreviations

CA-MRSA: 

Community-associated methicillin-resistant Staphylococcus aureus

HA-MRSA: 

Healthcare-associated methicillin-resistant Staphylococcus aureus

MRSA: 

Methicillin-resistant Staphylococcus aureus

PVL: 

Panton-Valentine Leukocidin

SA: 

Staphylococcus aureus

Declarations

Acknowledgement

Not applicable

Funding

No funding was obtained for this study.

Availability of data and materials

Please contact author for data requests.

Authors’ contributions

All authors have read and approved the final version of the manuscript. IO participated in the design of the study, collected data, helped in drafting the manuscript, and reviewed the final draft. AR participated in the design of the study, performed the molecular studies, helped in drafting the manuscript, and reviewed the final draft. AO participated in the design of the study, helped in drafting the manuscript, and reviewed the final draft. DG and AP conceived the study, collected and analyzed data, helped in drafting the manuscript, and wrote the final draft.

Authors’ information

Ido Orlin

The article was written as part of the requirements of the School of Medicine in the Galilee, Bar-Ilan University, for an MD degree

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

The study protocol was reviewed and approved by the Poriya-Baruch Padeh Medical Center Institutional Review Board/Ethics Committee and the Ethics Committee of Bar-Ilan University. The Ethics Committee approval number is: POR12–0011.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
The Faculty of Medicine in the Galilee, Bar-Ilan University, Galilee, Israel
(2)
National Staphylococcus aureus Reference Center, Central Laboratories, Israel Ministry of Health, Jerusalem, Israel
(3)
Pediatric Gastrointestinal Unit, Padeh Poriya Medical Center, Poriya, Tiberias, Israel
(4)
Pediatric Infectious Diseases Service, Galilee Medical Center, Nahariya, Israel
(5)
Clinical Microbiology Laboratory, Padeh Poriya Medical Center, Poriya, Hanna Senesh 818/2, Tiberias, Israel

References

  1. David M, Daum R. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 2010;23(3):616–87.View ArticlePubMedPubMed CentralGoogle Scholar
  2. David M, Glikman D, Crawford S, et al. What is community-associated methicillin-resistant Staphylococcus aureus? J Infect Dis. 2008;197(9):1235–43.View ArticlePubMedGoogle Scholar
  3. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10(3):505–20.PubMedPubMed CentralGoogle Scholar
  4. Glick S, Samson D, Huang E, et al. Screening for methicillin-resistant Staphylococcus aureus: A comparative effectiveness review. Am J Infect Control. 2014;42:148–55.View ArticlePubMedGoogle Scholar
  5. Gorwitz RJ, Kruszon-Moran D, McAllister SK, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis. 2008;197(9):1226–34.View ArticlePubMedGoogle Scholar
  6. Dulon M, Peters C, Schablon A, et al. MRSA carriage among healthcare workers in non-outbreak settings in Europe and the United States: a systematic review. BMC Infect Dis. 2014;14:363.View ArticlePubMedPubMed CentralGoogle Scholar
  7. Stubbs E, Pegler M, Vickery A, Harbour C. Nasal carriage of Staphylococcus aureus in Australian (pre-clinical and clinical) medical students. J Hosp Infect. 1994;27(2):127–34.View ArticlePubMedGoogle Scholar
  8. Berthelot P, Grattard F, Fascia P, et al. Is nasal carriage of methicillin-resistant Staphylococcus aureus more prevalent among student healthcare workers? Infect Control Hosp Epidemiol. 2004;25:364–5.View ArticlePubMedGoogle Scholar
  9. Güçlü E, Yavuz T, Tokmak A, et al. Nasal carriage of pathogenic bacteria in medical students: effects of clinic exposure on prevalence and antibiotic susceptibility. Eur Arch Otorhinolaryngol. 2007;264:85–8.View ArticlePubMedGoogle Scholar
  10. Higuchi W, Isobe H, Iwao Y, et al. Extensive multidrug resistance of coagulase-negative staphylococci in medical students. J Infect Chemother. 2007;13:63–6.View ArticlePubMedGoogle Scholar
  11. Adesida S, Abioye O, Bamiro B, et al. Associated risk factors and pulsed field gel electrophoresis of nasal isolates of Staphylococcus aureus from medical students in a tertiary hospital in Lagos, Nigeria. Braz J Infect Dis. 2007;11:63–9.View ArticlePubMedGoogle Scholar
  12. Baliga S, Bansil R, Suchitra U, et al. Nasal carriage of methicillin-resistant Staphylococcus aureus in medical students. J Hosp Infect. 2008;68:91–2.View ArticlePubMedGoogle Scholar
  13. Slifka J, Nettleman M, Dybas L, et al. Is acquisition of methicillin-resistant Staphylococcus aureus an occupational hazard for medical students? Clin Infect Dis. 2009;49:482–3.View ArticlePubMedGoogle Scholar
  14. Ma X, Sun D, Wang S, et al. Nasal carriage of methicillin-resistant Staphylococcus aureus among preclinical medical students: epidemiologic and molecular characteristics of methicillin-resistant S. aureus clones. Diagn Microbiol Infect Dis. 2011;70:22–30.View ArticlePubMedGoogle Scholar
  15. Roberts C, Soge O, Horst A, et al. Methicillin-resistant Staphylococcus aureus from dental school clinic surfaces and students. Am J Infect Control. 2011;39:628–32.View ArticlePubMedGoogle Scholar
  16. Chamberlain R, Singh K. Prevalence of methicillin resistant Staphylococcus aureus in nasal samples from preclinical second-year medical students. Mo Med. 2011;108(5):373–6.PubMedGoogle Scholar
  17. Kitti T, Boonyonying K, Sitthisak S. Prevalence of methicillin-resistant Staphylococcus aureus among university students in Thailand. Southeast Asian J Trop Med Public Health. 2011;42:1498–504.PubMedGoogle Scholar
  18. Gualdoni A, Lingscheid T, Tobudic S, et al. H. Low nasal carriage of drug-resistant bacteria among medical students in Vienna. GMS Krankenhhyg Interdiszip. 2012;7:Doc04.PubMedPubMed CentralGoogle Scholar
  19. Bettin A, Causil C, Reyes N. Molecular identification and antimicrobial susceptibility of Staphylococcus aureus nasal isolates from medical students in Cartagena, Colombia. Braz J Infect Dis. 2012;16:329–34.View ArticlePubMedGoogle Scholar
  20. Mahmutović Vranić S, Puškar M. Staphylococcus aureus carriage among medical students. Med Glas (Zenica). 2012;9:325–9.Google Scholar
  21. Chen C, Chen Y, Huang C. Nasal carriage rate and molecular epidemiology of methicillin-resistant Staphylococcus aureus among medical students at a Taiwanese university. Int J Infect Dis. 2012;16:e799–803.View ArticlePubMedGoogle Scholar
  22. Syafinaz M, Nur Ain Z, Nadzirahi N, et al. Staphylococcus aureus nasal carriers among medical students in a medical school. Med J Malaysia. 2012;67:636–8.PubMedGoogle Scholar
  23. Bellows C, Smith A, Wheeler J, Morici L. Nasal carriage of methicillin-resistant Staphylococcus aureus among students at a Louisiana medical university. Braz J Infect Dis. 2013;17:118–9.View ArticlePubMedGoogle Scholar
  24. Cirković I, Djukić S, Vuković D, et al. Nasal carriage of methicillin-resistant Staphylococcus aureus among medical students of Belgrade University. Srp Arh Celok Lek. 2013;141:349–53.View ArticlePubMedGoogle Scholar
  25. Trépanier P, Tremblay C, Ruest A. Methicillin-resistant Staphylococcus aureus colonization among medical residents. Can J Infect Dis Med Microbiol. 2013;24:e39–41.PubMedPubMed CentralGoogle Scholar
  26. Treesirichod A, Hantagool S, Prommalikit O. Nasal carriage and antimicrobial susceptibility of Staphylococcus aureus among medical students at the HRH Princess Maha Chakri Sirindhorn Medical Center, Thailand: a follow-up study. J Infect Public Health. 2014;7:205–9.View ArticlePubMedGoogle Scholar
  27. Zakai A. Prevalence of methicillin-resistant Staphylococcus aureus nasal colonization among medical students in Jeddah, Saudi Arabia. Saudi Med J. 2015;36:807–12.View ArticlePubMedPubMed CentralGoogle Scholar
  28. Collazos Marín F, Estupiñan Arciniegas G, Chavez Vivas M. Characterization of Staphylococcus aureus isolates that colonize medical students in a hospital of the city of Cali, Colombia. Int J Microbiol. 2015;2015:358489.View ArticlePubMedPubMed CentralGoogle Scholar
  29. Ho P-L, Lai EL, Chow K-H. Carriage of methicillin-susceptible and -resistant Staphylococcus aureus by medical students in Hong Kong. J Hosp Infect. 2015;91(2):184–5.View ArticlePubMedGoogle Scholar
  30. Baek S, Baek H, Yoo J. Higher nasal carriage rate of methicillin-resistant Staphylococcus aureus among dental students who have clinical experience. J Am Dent Assoc. 2015;147:348–53.View ArticleGoogle Scholar
  31. Okamo B, Moremi N, Seni J, et al. Prevalence and antimicrobial susceptibility profiles of Staphylococcus aureus nasal carriage among pre-clinical and clinical medical students in a Tanzanian University. BMC Res Notes. 2016;9:47.View ArticlePubMedPubMed CentralGoogle Scholar
  32. Ansari S, Gautam R, Shrestha S, et al. Risk factors assessment for nasal colonization of Staphylococcus aureus and its methicillin resistant strains among pre-clinical medical students of Nepal. BMC Res Notes. 2016;9:214.View ArticlePubMedPubMed CentralGoogle Scholar
  33. Clinical and Laboratory Standards Institute/NCCLS. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement. Wayne: Clinical and Laboratory Standards Institute; 2014. CLSI/NCCLS Document M100-S24.Google Scholar
  34. McClure A, Conly M, Lau V, et al. Novel multiplex PCR assay for detection of the staphylococcal virulence marker Panton-Valentine leukocidin genes and simultaneous discrimination of methicillin-susceptible from -resistant staphylococci. J Clin Microbiol. 2006;44(3):1141–4.View ArticlePubMedPubMed CentralGoogle Scholar
  35. Zhang K, McClure A, Elsayed S, et al. Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2005;43(10):5026–33.View ArticlePubMedPubMed CentralGoogle Scholar
  36. Harmsen D, Claus H, Witte W, et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol. 2003;41(12):5442–8.View ArticlePubMedPubMed CentralGoogle Scholar
  37. Tenover C, Arbeit D, Goering V, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33(9):2233–9.PubMedPubMed CentralGoogle Scholar
  38. Adler A, Chmelnitsky I, Shitrit P, et al. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Israel: dissemination of global clones and unique features. J Clin Microbiol. 2012;50(1):134–7.View ArticlePubMedPubMed CentralGoogle Scholar
  39. Shitrit P, Openhaim M, Reisfeld S, et al. Characteristics of SCCmec IV and V Methicillin-Resistant Staphylococcus aureus (MRSA) in Israel. Isr Med Assoc J. 2015;17(8):470–5.PubMedGoogle Scholar
  40. Biber A, Parizade M, Taran D, et al. Molecular epidemiology of community-onset methicillin-resistant Staphylococcus aureus infections in Israel. Eur J Clin Microbiol Infect Dis. 2015;34(8):1603–13.View ArticlePubMedGoogle Scholar
  41. Grundmann H, Aanensen DM, van den Wijngaard CC, et al. Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: A molecular-epidemiological analysis. PLoS Med. 2010;7:e1000215.View ArticlePubMedPubMed CentralGoogle Scholar
  42. Dall’Antonia M, Coen PG, Wilks M, et al. Competition between methicillin-sensitive and -resistant Staphylococcus aureus in the anterior nares. J Hosp Infect. 2005;61:62–7.View ArticlePubMedGoogle Scholar
  43. Mongkolrattanothai K, Gray BM, Mankin P, et al. Simultaneous carriage of multiple genotypes of Staphylococcus aureus. J Med Microbiol. 2011;60:317–22.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement

Antimicrobial Resistance & Infection Control

ISSN: 2047-2994

Contact us